Land Grab13 May 2018 09:17
Whilst we have seen here and elsewhere, the Aim market doesn't tend to get too excited by the issuing of patents .. However, scancells patents arnt patents covering individual therapies or molecules .. They are patents that secure the door to a whole world of therapies, some being worked on and some probably not even discovered yet ! Moditope and immunobody are protected 'methods' of producing therapies ..
Whether the market values this or not is yet to be seen .. But what is unquestionable is that if any party out there is looking at scancell and its technology, these patents will add to the 'security' of entering any deal or collaboration with them.
(And of course any therapy produced from a result of these technologies can be doubly protected by a 'composition of matter' patent filed once LD is happy with it, like for example scib1!).
Just some opinions as ever ... All exciting stuff !
Take care all ..